Skip to content

Depression research published in 2025

Page 21 of 39: studies 401 to 420 of 761, newest first. Back to the depression overview

Studies

[Psilocybin in the setting of treatment-resistant unipolar depression: A case report].

L'Encephale May 23, 2025 Maroussia Dumenil, Gabriel Cordova, Wissam El-Hage 1 citation

Current antidepressants have shown certain limitations in the treatment of unipolar depression. Their long onset of action, interactions, and side effects are obstacles to achieving lasting remission of this prevalent, often chronic or recurrent, pathology. Faced with this clinical necessity, research efforts have intensified in recent years around psychedelic drugs, with a particular focus on...

Bioactive ketamine metabolite exerts in vivo neuroplastogenic effects to improve hippocampal function in a treatment-resistant depression model.

Cell Reports May 21, 2025 Lace M Riggs, Sage Aronson, Ta-Chung M. Mou et al. 2 citations

An acute increase in excitatory synaptic transmission contributes to the rapid antidepressant actions of neuroplastogens, including ketamine and its bioactive metabolite, (2R,6R)-hydroxynorketamine (HNK). It is hypothesized that drug-induced metaplastic changes in synaptic strength account for therapeutically relevant behavioral adaptations in vivo. Using the plasticity-deficient Wistar Kyoto...

Protocol for a cluster-randomized clinical trial to evaluate the effectiveness of mindfulness-based cognitive therapy for depression, implemented in Vietnamese Buddhist pagoda.

BMC Psychology May 20, 2025 Bahr Weiss, Van Vu, Hoang-Minh Dang et al. 2 citations

Depression presents a substantial world-wide public health burden. Although evidence-based treatments exist, the majority of individuals with depression do not receive evidence-based treatments, particularly in low-and-middle-income countries, due to (a) scarcity of mental health professionals, and (b) mental health-related stigma. One approach addressing these issues is task-shifting, transfer...

DOI: 10.1186/s40359-025-02754-5 (opens in new tab) Full text (opens in new tab) Mbct Buddhist meditation Mindfulness-based cognitive therapy Pagoda +5

The Associations Between Deviation From the Balanced Time Perspective and Depression and Anxiety: The Moderator Role of Mindfulness in a Two-Wave Study

Psychological Reports May 19, 2025 Ayşe Altan‐Atalay, Hamed Abdollahpour Ranjbar, Seda Altıntaş 2 citations

Deviation from the balanced time perspective (DBTP) refers to difficulties in switching between different time frames in a flexible way by considering the situational demands. DBTP is associated with higher levels of depression and anxiety. Mindfulness acts as a protective mechanism against depression and anxiety. The current study examined the moderator role of mindfulness in the relationship...

Mindfulness-Based Interventions for Mental Health Outcomes in Frontline Healthcare Workers During the COVID-19 Pandemic: A Randomized Controlled Trial.

Journal of General Internal Medicine May 19, 2025 Marieke Arts-De Jong, Dirk E. M. Geurts, Philip Spinhoven et al. 2 citations

The COVID-19 pandemic significantly impacted the mental health of frontline healthcare workers (HCWs), but solid evidence on psychological interventions for HCWs remains limited. Whether an adjusted therapist-assisted Mindfulness-based Stress Reduction group intervention (adjusted MBSR) is superior to a minimal self-guided mindfulness-based intervention (self-guided MBI) in improving mental...

Potential Antidepressive Effects of R-ketamine in Patients with Treatment Resistance Depression

Carleton undergraduate journal of science. May 16, 2025 Sumika Egner

Ketamine has a long history as an anesthetic but has recently demonstrated antidepressant effects at sub-anesthetic doses (Matveychuk et al., 2020). For individuals with treatment-resistant depression (TRD), typical antidepressants are frequently ineffective, whereas ketamine’s unique mechanisms have demonstrated promising results in reducing depressive symptoms where other treatments have...

Emotion, Motivation, Reasoning, and How Their Brain Systems Are Related.

Brain Sciences May 16, 2025 Edmund T Rolls 7 citations

A unified theory of emotion and motivation is updated in which motivational states are states in which instrumental goal-directed actions are performed to obtain anticipated rewards or avoid punishers, and emotional states are states that are elicited when the (conditioned or unconditioned) instrumental reward or punisher is or is not received. This advances our understanding of emotion and...

Esketamine ameliorates prenatal stress-induced postpartum depression and sex-related behavioral differences in adolescent progeny.

Neuropharmacology May 15, 2025 Yazhou Wen, Jin Zhou, Huiling Yu et al. 2 citations

Prenatal stress leads to postpartum depression and is associated with developmental issues in offspring. Esketamine quickly and effectively prevents or treats postpartum depression. However, the long-term effects of esketamine on progeny development are unknown. CRS during pregnancy was used to establish the postpartum depression animal model. After confirming pregnancy, all mice were randomly...

DOI: 10.1016/j.neuropharm.2025.110354 (opens in new tab) Full text (opens in new tab) Chronic restraint stress Postpartum depression ppd Postnatal depression Psychiatric care +2

Mindfulness in Mental Health and Psychiatric Disorders of Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Pediatric Reports May 14, 2025 Bruno Daniel Carneiro, Daniel Humberto Pozza, José Tiago Costa-Pereira et al. 6 citations

Mindfulness-Based Interventions (MBIs) are important tools to address mental health issues in children and adolescents. However, previous studies provided variable results that suggest that the effectiveness of those third-wave Cognitive Behavioral Therapies remains uncertain. The main objective is to assess the impact of MBIs on anxiety, depression, and stress in children and adolescents. The...

A brief online mindfulness intervention: study protocol for Indonesian undergraduate students, a randomized controlled trial.

Trials May 13, 2025 Ka Yan, Nessa Ikani, Cleoputri Yusainy et al. 1 citation

Elevated levels of stress, anxiety, and depression persist among undergraduate students in Eastern countries, including Indonesia. Access to mental healthcare resources, however, remains difficult and costly for most young people. Furthermore, there is a strong tendency to avoid seeking professional help. The primary aim of this study is to investigate the effects of a brief 14-day online...

Mindful Non-reactivity, Anxiety, Depression, and Perceived Stress as Mediators of the Mindfulness Virtual Community Intervention: Pathways to Enhance Mental Health in University Students.

JMIR Mental Health May 13, 2025 Meysam Pirbaglou, Christo El Morr, Farah Ahmad et al. 2 citations

Mindfulness-based interventions (MBIs) are widely employed in mental health promotion and treatment. Despite widespread evidence of effectiveness with different populations and delivery modes, there are sparse findings concerning the mechanisms of action in MBIs. This study, based on a secondary evaluation of two randomized controlled trials (RCTs) with student participants, was aimed at...

Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression.

The British Journal of Psychiatry May 13, 2025 Shabnam Hossein, Manivel Rengasamy, Aiyedun Uzamere et al. 3 citations

Understanding the effects of ketamine on depressive symptoms could help identify which patients might benefit and clarify its mechanism of action in both the early (≤1 day post-infusion) and late (e.g. 2-30 days post-infusion) post-infusion periods. Symptom network analyses could provide complementary information regarding relationships between symptoms. To identify the effects of ketamine on...

DOI: 10.1192/bjp.2024.276 (opens in new tab) Full text (opens in new tab) Ketamine Biological Out-patient treatment Randomised controlled trial +5

A quasiexperimental study of assessing the impact of stress management program on health science students at Kuwait University.

Scientific Reports May 12, 2025 Naser M Alotaibi, Latifah Alenezi, Feddah M Ahmad et al. 1 citation

The purpose of this research was to study the effectiveness of a stress management program among students at the Health Science Center (HSC), Kuwait University. This study utilized a quasiexperimental research design in which the participants were randomly assigned to one of two groups: (1) the control group or (2) the experimental (intervention) group. The participants received a comprehensive...

Correlations between major depressive disorder, splenic morphology, and immune function.

BMC Psychiatry May 12, 2025 Zouqing Lin, Xiaoyan Xu, Kai Zhang et al. 3 citations

To analyze the symptoms, courses, and severities of depressive disorder, as well as the morphological changes in the spleens and related immune mechanisms, we recruited patients with first-episode or recurrent major depressive disorder (MDD) (patient group) and healthy controls (normal group) matched in age and gender. We measured their plasma MICB (pg/ml), ULBP1 (ng/ml), and splenic volume...

Safety Profile and Suicidality Associated with the Use of Esketamine in the Treatment of Major Depressive Disorder in European Countries: An EudraVigilance Database Analysis.

Pharmaceuticals May 9, 2025 Ilaria Ammendolia, Carmen Mannucci, Emanuela Esposito et al. 2 citations

Background/Objective: Major depressive disorder (MDD) is a common mental disorder, with a significant portion of patients developing treatment-resistant depression (TRD). Esketamine is an antagonist of the N-methyl-D-aspartate receptor indicated as a nasal spray in combination with other antidepressants for adults with TRD. Signals of suspected adverse reactions (SARs) to esketamine from the...

The longitudinal influence of cyberbullying victimization on depression, self-esteem and academic burnout among Chinese adolescents: mindfulness as a mediator

Frontiers in Psychiatry May 8, 2025 Yanping Lu, Longxin Dang, Yuan Tao

Cyberbullying victimization (CV) has been linked to numerous adverse psychological outcomes among adolescents. While previous research has established associations between CV and negative outcomes including depression, diminished self-esteem, and academic burnout, the potential protective mechanisms in these relationships remain underexplored. This longitudinal study investigated the mediating...

The Role of a 10-Week Mindfulness-Based Cognitive Behavioral Therapy Intervention in Managing Depression, Anxiety, and Stress Among the Elderly: A Quasi-Experimental Study

Journal of Neonatal Surgery May 8, 2025 Rachna Garg, Shubhagata Awasthi, Naveen Gupta

This study investigates the effectiveness of a 10-week Mindfulness-Based Cognitive Behavioral Therapy (MBCBT) intervention in reducing symptoms of depression, anxiety, and stress among elderly individuals. Psychological distress is increasingly prevalent in older adults, yet non-pharmacological interventions remain underutilized in geriatric care. Employing a quasi-experimental pre-post design,...

Enhanced ERK activity extends ketamine's antidepressant effects by augmenting synaptic plasticity.

Science May 8, 2025 Z Zack Ma, Natalie J Guzikowski, Ji-Woon Kim et al. 44 citations

Repeated ketamine treatment to maintain a rapid antidepressant effect can lead to side effects over time, highlighting an unmet clinical need for sustaining this drug's antidepressant action from a single administration. Ketamine-induced synaptic potentiation at CA3-CA1 synapses has been proposed to be a key synaptic substrate for antidepressant action. Here, we found that ketamine-induced...

DOI: 10.1126/science.abb6748 (opens in new tab) Full text (opens in new tab) Depression Ketamine therapy Mental health treatment Brain chemistry

(R)-ketamine induces mGlu5 receptor-dependent antidepressant-like effects in the chronic unpredictable mild stress model of depression in mice.

Psychopharmacology May 8, 2025 Agnieszka Pałucha-Poniewiera, Anna Rafało-Ulińska, Agata Faron-Górecka et al. 1 citation

(S)-Ketamine, which is used to treat depression, has significant undesirable effects and has potential for abuse. A safe alternative to (S)-ketamine is (R)-ketamine. The relationship between (R)-ketamine and the mGlu5 receptor is unknown, although screening tests indicate the possibility of potentiation of the antidepressant effect of (R)-ketamine by the mGlu5 receptor negative allosteric...